BlueRock Therapeutics
Healthcare & Life Sci
Company overview
BlueRock Therapeutics is a clinical-stage cell therapy company. It develops medicines that replace damaged or lost cells caused by disease. Its lead product, Bemdaneprocel, is an investigational cell therapy for Parkinson's disease currently in Phase III clinical trials. Another product, OpCT-001, is an investigational cell therapy that has received FDA Orphan Drug Designation.
Currently, there are no job openings at BlueRock Therapeutics. Over the last 30 days, 0 jobs were added and 0 were removed. BlueRock Therapeutics is an H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- 2 offices, United States